SIMBRINZA bulk active fine chemical suppliers

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
BenchChem	⤷ Get Started Free	B1243177	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 27, 2025

Introduction

Simbrinza, a combination ophthalmic medication used primarily to reduce intraocular pressure in patients with glaucoma or ocular hypertension, comprises two active pharmaceutical ingredients: brimonidine tartrate and brinzolamide. Ensuring reliable and high-quality sourcing of these APIs is critical for manufacturing, distribution, and compliance with regulatory standards. This article provides an in-depth overview of sourcing strategies, key suppliers, and industry considerations for bulk brimonidine tartrate and brinzolamide APIs used in Simbrinza.

Understanding the APIs in Simbrinza

Brimonidine Tartrate: An alpha-2 adrenergic receptor agonist that decreases aqueous humor production, thereby lowering intraocular pressure. Its chemical purity, stability, and bioavailability are critical.

Brinzolamide: A carbonic anhydrase inhibitor that reduces aqueous humor secretion. Its API demands stringent quality control and compliance with pharmacopeia standards.

The combination of these APIs in Simbrinza offers a synergistic therapeutic effect, emphasizing the need for consistent high-purity APIs from trusted manufacturers.

Global API Market Overview for Ophthalmic Medications

The pharmaceutical API market caters to multiple therapeutic areas, with ophthalmology representing a growing segment. The demand for high-quality APIs like brimonidine tartrate and brinzolamide is driven by increasing glaucoma prevalence and advancements in drug formulation. Suppliers must comply with stringent regulatory standards, including cGMP (current Good Manufacturing Practices) and ISO certifications, to ensure product safety and efficacy.

Key Sources of Brimonidine Tartrate API

Leading Manufacturers and Suppliers

Sanfida (Shandong Sanfida Pharmaceutical Co., Ltd.)
- Specializes in alpha-adrenergic agonist APIs, including brimonidine tartrate.
- Offers APIs conforming to USP, EP, and JP standards.
- Emphasizes quality control through rigorous testing and cGMP compliance.
Zhejiang Hisunia Pharmaceutical Co., Ltd.
- Provides bulk brimonidine tartrate with extensive analytical documentation.
- Supplies global markets, with a focus on Asia and Europe.
Apex Pharmaceuticals
- An Indian API manufacturer with a significant portfolio in ophthalmic-active ingredients.
- Meets international regulatory standards and holds multiple certifications.
LGM Pharma
- Sourced from multiple manufacturing entities globally, offering flexibility and quality assurance for brimonidine tartrate.
Pharmex S.r.l. (Italy)
- Supplies high-purity brimonidine tartrate as part of a wide ophthalmic API portfolio.
- Holds certifications aligning with European market requirements.

Regulatory & Quality Considerations

Manufacturers aiming to supply for ophthalmic uses must provide comprehensive documentation:

Certificates of Analysis (CoA)
Certificates of Compliance (CoC)
Stability data conforming to ICH guidelines

Key Sources of Brinzolamide API

Outstanding Suppliers and Manufacturers

Hubei Hwankai Pharmaceutical Co., Ltd.
- Chinese manufacturer with a focus on ophthalmic APIs, including brinzolamide.
- Complies with Chinese GMP and provides documentation suitable for international markets.
Luye Pharma Group
- A reputable Chinese pharmaceutical company offering certified bulk brinzolamide APIs.
- Known for high-purity production and consistent batch-to-batch quality.
BASF SE
- Industry leader in specialty chemicals and APIs, with a portfolio encompassing ophthalmic compounds.
- Offers high-quality API with extensive regulatory dossiers.
CordenPharma (part of the International Chemical Investors Group)
- Provides custom synthesis, including brinzolamide, with robust quality assurance processes.
TEVA Pharmaceutical Industries Ltd.
- Globally recognized for producing high-quality APIs, including those used in ophthalmic medications.

Regulatory and Quality Assurance

Suppliers must adhere to international standards such as:

cGMP compliance
ISO certifications
Validated analytical methods

Documentation supporting bioequivalence, purity, and stability is essential.

Sourcing Considerations for Simbrinza’s APIs

Quality Assurance & Regulatory Compliance

Selecting suppliers requires rigorous review of quality controls, analytical validation, and documentation. Ensuring suppliers meet pharmacopeia requirements (USP, EP, JP) safeguards product efficacy and safety.

Supply Chain Reliability

Global supply chains are subject to geopolitical, logistical, and regulatory disruptions. Establishing relationships with multiple approved suppliers reduces risk.

Cost and Lead Times

Pricing varies significantly among regional manufacturers. Sourcing from low-cost regions like India and China offers economic benefits, but warrants careful quality oversight.

Custom Synthesis & Exclusivity

Rare APIs or formulations may require custom manufacturing, emphasizing partnerships with OEMs offering development and scalable production.

Industry Trends and Future Outlook

The market for ophthalmic APIs is projected to grow, aligned with increasing prevalence of glaucoma worldwide. Bio-similars and innovative manufacturing techniques, including continuous manufacturing and green chemistry, are set to influence sourcing strategies. Regulatory evolution necessitates ongoing supplier qualification and documentation.

Increasing demand has prompted API manufacturers to invest in capacity expansion and quality systems upgrades. Companies leveraging APIs from accredited suppliers will be better positioned to meet regulatory expectations and market growth.

Conclusion

Reliable sourcing of brimonidine tartrate and brinzolamide APIs is foundational for the manufacturing of Simbrinza. Leading global suppliers, including Sanfida, Luye Pharma, and BASF, provide high-quality, compliant APIs for ophthalmic applications. Business professionals should prioritize supplier due diligence, regulatory compliance, and supply chain resilience. As the ophthalmic API market evolves, fostering strong supplier relationships and staying aligned with regulatory standards will ensure continuous supply and product integrity.

Key Takeaways

The demand for high-quality bulk APIs for Simbrinza underscores the importance of selecting reputable manufacturers compliant with cGMP and international pharmacopeia standards.
Suppliers such as Sanfida, Luye Pharma, BASF, and CordenPharma are key global sources of brimonidine tartrate and brinzolamide APIs, offering rigorous quality assurance.
Due diligence should include reviewing documentation, certifications, stability data, and manufacturing capabilities to mitigate supply chain risks.
Market trends indicate ongoing capacity expansion and technological innovations, favoring suppliers committed to quality and regulatory compliance.
Establishing diversified procurement channels enhances supply security amid global logistical uncertainties.

FAQs

1. Are there regional differences in API quality standards for ophthalmic ingredients?
Yes. While the US (USP), Europe (EP), and Japan (JP) pharmacopeias set rigorous standards, regional manufacturers may vary in certification and quality assurance measures. Buyers should verify that suppliers meet the required standards for their target markets.

2. What are the critical quality parameters for brimonidine tartrate and brinzolamide APIs?
Purity, potency, residual solvent levels, ash content, microbial contamination, and stability are essential quality attributes. Certificates of analysis from GMP-compliant manufacturers should confirm conformance.

3. How can companies mitigate risks associated with API supply disruptions?
By establishing relationships with multiple qualified suppliers, maintaining safety stock inventories, and engaging in supplier audits and qualification processes.

4. Is screening for sustainable and green manufacturing practices important?
Increasingly, yes. Many regulators and consumers favor suppliers adopting environmentally friendly processes, which can also impact long-term supply stability.

5. Can APIs be sourced directly from OEMs or only through intermediaries?
Both options exist. Direct sourcing from OEMs provides control but requires tighter qualification. Intermediaries often offer flexibility and broader portfolio access but necessitate thorough supplier qualification.

References

U.S. Pharmacopeia (USP). Brimonidine Tartrate Monograph.
European Pharmacopoeia (EP). Brimonidine Tartrate and Brinzolamide Standards.
IMS Health Reports. Global Ophthalmic API Market Outlook.
Company websites and certifications of Sanfida, Luye Pharma, BASF, and CordenPharma.
International Conference on Harmonisation (ICH) guidelines on stability testing and quality assurance.

Bulk Pharmaceutical API Sources for SIMBRINZA